A Prospective, Randomized and Open Label Study to Compare Efficacy, Safety and Quality of Life Impact of Topical Glutathione (2%) in Comparison to Topical Tranexamic Acid (3%) in Adult Melasma Patients

• Ngā kaituhi matua: Saurabh Bijalwan (Author), Gurpreet K. Randhawa (Author), Tejinder Kaur (Author)
• Hōputu: Pukapuka
• I whakaputaina: Dr. Annil Mahajan, 2024-07-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: The most common cause of facial melanoses is melasma. There is no universally efficacious melasma therapy and the gold standard therapy (triple combination cream) has multiple long term adverse effects. Topical glutathione is a relatively novel drug acting on key melasma pathology featur...